The fact that GPR43-deficient (Ffar2-KO) mice are completely protected from high-fat diet-induced obesity, dyslipidemia, and fatty liver [109] supports the importance of SCFAs/GPR43 signaling in the development of NAFLD. The gene discussed is FFAR2; the disease is fatty liver disease.